Scientific Information & News,
8Cancer Research Technology Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research…
An optimized bicistronic chimeric antigen receptor against GPC2 or CD276 overcomes heterogeneous expression in neuroblastoma
Overview of attention for article published in Journal of Clinical Investigation, August 2022
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (88th percentile)
-
Above-average Attention Score compared to outputs of the same age and source (64th percentile)
Readers on
- mendeley
- 55 Mendeley